FAQ

Dengue virus Ab.IgG:Titr:Pt:Ser:Qn

Known as: Dengue virus Ac IgG [Titre] Sérum ; Numérique, Dengue virus IgG Ab [Titer] in Serum, Dengue virus Ac IgG:Titre:Ponctuel:Sérum:Numérique 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2017
01220002017

Related topics

Related topics

8 relations
AntibodiesDengue VirusDengue virus AbImmunoglobulin G
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Dengue virus Ab.IgG:Titr:Pt:Ser:Qn
Titer
Virus
Immunoglobulin G
Serum
Dengue Virus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Modeling the Heterogeneity of Dengue Transmission in a City
Dengue fever is one of the most important vector-borne diseases in the world, and modeling its transmission dynamics allows for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2017
2017
Envelope-modified tetravalent dengue virus-like particle vaccine : implication for flavivirus 1 vaccine design 2 3
16 Dengue viruses (DENV) infect 50-100 million people each year. The spread of DENV17 associated infections is one of the most… (More)
  • table 1
  • table 2
Is this relevant?
2016
2016
Molecular and serological techniques to detect co-circulation of DENV, ZIKV and CHIKV in suspected dengue-like syndrome patients.
BACKGROUND Arboviruses are important emerging viruses worldwide. The signs and symptoms of Zika virus (ZIKV) infection are… (More)
Is this relevant?
2015
2015
An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
The immunogenicity and protective efficacy of a candidate tetravalent dengue virus purified inactivated vaccine (TDENV PIV… (More)
Is this relevant?
2013
2013
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.
Sylvatic dengue viruses (DENV) are both evolutionarily and ecologically distinct from human DENV and are maintained in an… (More)
Is this relevant?
2012
2012
Electrochemical impedance spectroscopy characterization of nanoporous alumina dengue virus biosensor.
The Faradaic electrochemical impedance technique is employed to characterize the impedance change of a nanoporous alumina… (More)
Is this relevant?
2011
2011
Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic.
BACKGROUND Because infection with any of the 4 Dengue virus serotypes may elicit both protective neutralizing antibodies and… (More)
Is this relevant?
2011
2011
Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
A recombinant live attenuated tetravalent dengue vaccine (TDV) is safe and immunogenic in adults and children in dengue-naïve… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naïve adults.
rDEN2/4Delta30(ME) is an attenuated chimeric dengue virus in which the prM and E structural proteins of the DEN4 candidate… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Live attenuated tetravalent dengue vaccine.
The development of a live attenuated tetravalent dengue vaccine is currently the best strategy to obtain a vaccine against dengue… (More)
Is this relevant?